By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
FDA Approves Merck & Co. (MRK)'s KEYTRUDA (Pembrolizumab) In Metastatic NSCLC For First-Line Treatment Of Patients Whose Tumors Have High PD-L1 Expression (Tumor Proportion Score [TPS] Of 50 Percent Or More) With No EGFR Or ALK Genomic Tumor Aberrations 10/25/2016 11:53:53 AM
Agilent Technologies Inc. (A) Receives Expanded FDA Approval For Use Of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic In Non-Small Cell Lung Cancer (NSCLC) 10/25/2016 11:34:22 AM
FDA Green Lights Spineology Inc.'s Rampart Duo Interbody Fusion System 10/25/2016 10:38:41 AM
Curetis Announces Positive Top Line Data From U.S. FDA Trial 10/25/2016 9:56:54 AM
Ethicon (JNJ) Release: EVARREST Fibrin Sealant Patch Gains FDA Approval on Expanded Indication for General Hemostasis 10/25/2016 8:38:30 AM
Portola (PTLA) Submits New Drug Application To FDA For Betrixaban For Extended Duration Prophylaxis Of Venous Thromboembolism In Acute Medically Ill Patients 10/25/2016 7:49:04 AM
Merck & Co. (MRK) Cements Lead Over Rivals After the FDA Grants Early Approval of Keytruda 10/25/2016 7:27:13 AM
FDA Reclassifies Johnson & Johnson (JNJ) Acclarent's Aera Eustachian Tube Balloon to a Class II Device 10/25/2016 7:11:41 AM
Harvard Experts Fret Over the Fallout From FDA’s OK for Sarepta (SRPT)’s Controversial DMD Drug 10/25/2016 6:38:06 AM
Bay Area's Global Blood Therapeutics (GBT) and the FDA Finally Reach Agreement on Trial Design for Sickle Cell Disease Drug 10/25/2016 5:53:18 AM